Improving the Quality of Care for Patients with Atopic Dermatitis: Integrating Measurement-Based Tools Into Your Clinical Practice

Improving the Quality of Care for Patients with Atopic Dermatitis: Integrating Measurement-Based Tools Into Your Clinical Practice is organized by CME Outfitters, LLC

Premiere Date: Thursday, December 13, 2018
Credit Expiration Date: Thursday, December 31, 2020

This activity offers CE credit for:
• Physicians (CME)
• Nurses (CNE)
• Pharmacists (ACPE)
• ABIM (MOC)
• Other

All other clinicians will receive a Certificate of Attendance stating this activity was certified for AMA PRA Category 1 Credit™

Credit Information:
CME Credit (Physicians):
CME Outfitters, LLC, designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CNE Credit (Nurses):
Provider approved by the California Board of Registered Nursing, Provider Number CEP 15510, for 1.5 contact hours. 

Note to Nurse Practitioners and Clinical Nurse Specialists: the content of this activity pertains to pharmacology. Earn up to 1.5 contact hours of pharmacotherapeutic contact hours. 

CPE Credit (Pharmacists):
ACPE CME Outfitters, LLC, is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. 1.5 contact hours (0.15 CEUs) Universal Activity Number: 

Statement of Need
Attitudes about atopic dermatitis are evolving with the emergence of new and effective treatments. With the average dermatologist having not enjoyed caring for patients with AD for decades, there is little to no consensus in current practice about validated tools to assess and monitor the severity of the diseases and no consistent use of diagnostic or assessment tools. This lack of knowledge and education leads to confusion, poor recognition, and absence of assessment of AD severity. 

the use of patient-reported outcomes such as the Patient-Oriented Eczema Measure (POEM) are often underused in clinical practice despite being simple, valid, repeatable, and easy to interpret. The use of tools such as POEM is important to capture the impact of AD on health-related quality of life. 

In this CME Outfitters Live and On Demand, expert faculty will discuss diagnostic assessment and measurement of symptom severity in AD including patient-reported outcomes, with the goal of educating clinicians regarding tools for diagnosis and assessment that can be integrated into their clinical practice.

Learning Objectives
At the end of this CE activity, participants should be able to:
• Apply the Hanifin Rajka criteria and/or the American Academy of Dermatology (AAD) criteria to facilitate the diagnosis of AD in clinical practice
• Incorporate the POEM assessment scale into clinical practice to monitor disease severity and response to treatment.
• Document the utilization of clinical assessment tools and results form their use in patients' charts.
The following learning objectives pertain only to those requesting CNE or CPE credit:
• Summarize the Hanifin Rajka criteria and/or the American Academy of Dermatology (AAD) criteria used to diagnose AD.
• Describe the POEM assessment scale for monitoring disease severity and response to treatment.
• Identify the tools and clinical assessment results that should be documented in patients' charts.

Additional details will be posted as soon as they are available.